Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Journal of Pathology

Volumn 189, Issue 1, 1999, Pages 12-19

  Walboomers, Jan M M ^a   Jacobs, Marcel V ^a   Manos, M Michele ^b   Bosch, F Xavier ^c   Kummer, J Alain ^a   Shah, Keerti V ^b   Snijders, Peter J F ^a   Peto, Julian ^d   Meijer, Chris J L M ^a   Muñoz, Nubia ^e  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cervical carcinoma; Epidemiology; Histology; HPV PCR; HPV serology

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

BIOLOGY; CANCER; CERVICAL CANCER; CLINICAL RESEARCH; DISEASES; EPIDEMIOLOGY; EXAMINATIONS AND DIAGNOSES; HEALTH; HISTOLOGY; HPV; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; NEOPLASMS; PUBLIC HEALTH; RESEARCH METHODOLOGY; RESEARCH REPORT; VIRAL DISEASES; WORLD;

ANTIBODIES, VIRAL; BASE SEQUENCE; BLOTTING, SOUTHERN; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; DNA PRIMERS; DNA, VIRAL; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; PREVALENCE; REPRESSOR PROTEINS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; UTERINE CERVICAL NEOPLASMS; WORLD HEALTH;

EID: 0032840918     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F     Document Type: Article

References (32)

1. IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses, Vol. 64, Human Papillomaviruses. Lyon: International Agency for Research on Cancer, 1995.
2. Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.
3. Walboomers JMM, Meijer CJLM. Do HPV-negative cervical carcinomas exist? J Pathol 1997; 181: 253-254.
4. Schwarz E, Freeze UK, Gissmann L, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985: 314: 111-114.
5. Dürst M, Kleinheinz M, Hots M, Gissmann L. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumors. J Gen Virol 1985; 66: 1515-1522.
6. Choo K, Lee H, Pan C, et al. Sequence duplication and internal deletion in the integrated human papillomavirus type 16 genome cloned from a cervical carcinoma. J Virol 1987; 62: 1659-1666.
7. Wagatsuma M, Hashimoto K, Matsakura T. Analysis of integrated human papillomavirus type 16 DNA in cervical cancer: amplification of viral sequences together with cellular flanking sequences. J Virol 1990; 64: 813-821.
8. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. In: zur Hausen H, ed. Human Pathogenic Papillomaviruses. Heidelberg: Springer-Verlag, 1994; 133-516.
9. Müller M, Viscidi R, Sun Y, et al. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology 1992; 187: 508-514.
10. Viscidi R, Sun Y, Tsuzaki B, Bosch FX, Muñoz N, Shah K. Serologic response in human papillomavirus-associated invasive cervical cancer. Int J Cancer 1993; 55: 780-784.
11. Sun Y, Eluf-Neto J, Bosch FX, et al. Human papillomavirus (HPV)-related serologic markers of invasive cervical carcinoma in Brazil. Cancer Epidemiol Biomarkers Prev 1994; 3: 341-347.
12. Nonnenmacher B, Hubbert N, Kirnbauer R, et al. Serologic response to human papillomavirus type 16 (HPV-16) virus-like-particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J Infect Dis 1995; 172: 19-24.
13. Hamšiková E, Novák J, Hofmannová V, et al. Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls. J Infect Dis 1994; 170: 1424-1431.
14. Baay MFD, Quint WGV, Koudstaal J, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996; 34: 745-747.
15. Walboomers JMM, Mullink H, Melchers WG, et al. Sensitivity of in situ detection with biotmylated probes of human papillomavirus type 16 DNA in frozen tissue sections of squamous cell carcinomas of the cervix. Am J Pathol 1988; 131: 901-905.
16. van den Brule AJC, Cromme FV, Snijders PJF, et al. Nonradioactive RNA in situ hybridization detection of HPV 16-E7 transcripts in squamous cell carcinomas of the uterine cervix using confocal laser scan microscopy. Am J Pathol 1995; 139: 1037-1045.
17. Viscidi RP, Kotloff KL, Clayman B, Russ K, Shapiro S, Shah KV. Prevalence of antibodies to HPV 16 virus-like particles in relation to cervical HPV infection among college women. Clin Diagn Lab Immunol 1997; 4: 122-126.
18. de Roda Husman AM, Snijders PJF, Stel HV, van den Brule AJC, Meijer CJLM, Walboomers JMM. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 1995; 72: 412-417.
19. Myers O, Delius H, Icenogle J, et al. (eds). Human Papillomavirus Compendium: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos, NM: Los Alamos National Laboratory, 1994, 1995 and 1996.
20. van den Brule AJC, Meijer CJLM, Bakels V, Kenemans P, Walboomers JMM. Rapid human papillomavirus detection in cervical scrapes by combined general primers mediated and type-specific polymerase chain reaction. J Clin Microbiol 1991; 28: 2739-2743.
21. de Roda Husman AM, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by polymerase chain reaction. J Gen Virol 1995; 76: 1057-1062.
22. Tieben LM, ter Schegget J, Minnaar RP, et al. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 1993; 42: 265-280.
23. Jacobs MV, Snijders PJF, van den Brule AJC, Helmerhorst ThJM, Meijer CJLM, Walboomers JMM. A general primer GP5+/6+ mediated PCR-enzyme immunoassay method for rapid detection of 14 high risk and 6 low risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997; 35: 791-795.
24. de Roda Husman AM, Walboomers JMM, Meijer CJLM, et al. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes using polymerase chain reaction. Int J Cancer 1994; 56: 82-86.
25. Cullen AP, Reid R, Campion M, Lörincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991; 65: 606-612.
26. Berumen J, Casa L, Segura E, et al. Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes. Int J Cancer 1994; 56: 640-645.
27. Matsakura T, Koi S, Sugase M. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 1989; 172: 63-72.
28. Chichareon S, Herrero R, Muñoz N, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998; 90: 43-49.
29. Ngelangel C, Muñoz N, Bosch FX, et al. The causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998; 90: 50-57.
30. Chaouki N, Bosch FX, Muñoz N, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998; 75: 546-555.
31. McNeil C. HPV Vaccines for cervical cancer move toward clinic, encounter social issues. J Natl Cancer Inst 1997; 89: 1664-1666.
32. Meijer CJLM, Rozendaal L, van der Linden JC, Helmerhorst ThJM, Voorhorst FJ, Walboomers JMM. Human papillomavirus testing for primary cervical cancer screening. In: Franco E, Monsenego J, eds. New Developments in Cervical Cancer Screening and Prevention. Oxford: Blackwell Science, 1997; 338-347.